Laryngeal Diseases - 25 Studies Found
Recruiting |
: CyberKnife Accelerated Hemilarynx Stereotactic Radiotherapy Study for Early-stage Glottic Larynx Cancer : Early-stage Glottic Larynx Cancer : 2013-11-07 : Radiation: CyberKnife Accelerated Hemilarynx Stereotactic Radiotherapy CyberKnife Accelerated Hemilarynx |
Not yet recruiting |
: The Efficacy of Capsaicin Sensitivity Testing in Patients With Irritable Larynx Syndrome :
: 2014-02-11 : Other: Capsaicin cough challenge test The capsaicin cough challenge testing will be conducted in the pul |
Completed |
: Patient Selection for Hypoxia Modifying Treatments in Larynx Carcinomas : Larynx Cancer : 2005-09-09 |
Completed |
: Induction CT by Cisplatin, 5FU With or Without Docetaxel in Patients With T3 and T4 Larynx and Hypopharynx Carcinoma :
: 2005-09-09 : Drug: DOCETAXEL |
Completed |
: Radiotherapy With Cisplatin Versus Radiotherapy With Cetuximab After Induction Chemotherapy for Larynx Preservation :
: 2005-09-12 :
|
Completed |
: Docetaxel, Cisplatin (TP) + Radiation +/- Cetuximab in Larynx Carcinoma (CA) :
: |
Completed |
: Randomized Trial of ARCON in Larynx Cancer : Larynx Carcinoma : 2005-09-06 :
|
Recruiting |
: Treatment of Chronic Laryngitis With Amitriptyline : Laryngeal Diseases : 2015-09-09 :
|
Recruiting |
: A Phase II Trial of a Protease Inhibitor, Nelfinavir (NFV), Given With Definitive, Concurrent Chemoradiotherapy (CTRT) in Patients With Locally-Advanced, Human Papilloma Virus (HPV) Negative, Squamous Cell Carcinoma Larynx : Stage III, IVa, or IVb Squamous Cell Carcinoma of the Oral Cavity, Oropharynx, Larynx, or Hypopharynx : 2014-07-31 : Drug: Nelfinavir (Viracept®) 1250 mg |
Completed |
: A Phase I/II Study of the Use of Intensity Modulated Radiotherapy (IMRT) in Cancer of the Thyroid, Larynx and Hypopharynx :
|